… Addition of ezetimibe 10 mg/d to moderate-intensity statin therapy can achieve the same
percent LDL-C lowering as that achieved with high-intensity statin therapy. S4.3-14 In this RCT, …

Resistant hypertension is a common clinical problem faced by both primary care clinicians
and specialists. While the exact prevalence of resistant hypertension is unknown, clinical …

As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-1)
of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

All cancers are caused by somatic mutations; however, understanding of the biological
processes generating these mutations is limited. The catalogue of somatic mutations from a …

… An alternative representation could be obtained in this case since div D = 0 and so we could
take D = curl A'. This may be convenient in certain circumstances but the analysis, which is …

We report the final redshift release of the 6dF Galaxy Survey (6dFGS), a combined redshift
and peculiar velocity survey over the southern sky (|b| > 10). Its 136 304 spectra have yielded …

Background Intratumor heterogeneity may foster tumor evolution and adaptation and hinder
personalized-medicine strategies that depend on results from single tumor-biopsy samples. …

… Authors Womack, Jones, and Roos provided a comprehensive description of the entire
lean system. They exhaustively documented its advantages over the mass production model …

… PSIPRED (Jones, 1999a) carries out a reliable secondary structure … (Jones, 1999b) quickly
and reliably recognizes the fold of a protein and MEMSAT 2 (Jones et al., 1994; Jones, 1998) …

Cancers arise owing to mutations in a subset of genes that confer growth advantage. The
availability of the human genome sequence led us to propose that systematic resequencing of …